{
  "id": "mhgap#screening_cues_893a4420",
  "content": "iris.who.int/handle/10665/371091).\n125. Towards a dementia-inclusive society: WHO toolkit\nfor dementia-friendly initiatives (DFIs). Geneva: 133. The interagency health kit 2017: medicines\nWorld Health Organization; 2021 (https://iris.who. and medical devices for 10 000 people for\nint/handle/10665/343780). approximately three months. Geneva: World\nHealth Organization; 2019 (https://iris.who.int/\n126. Burley CV, Livingston G, Knapp MR, Wimo A,\nhandle/10665/279428).\nNorman R, Brodaty H. Time to invest in prevention\nand better care of behaviors and psychological 134. Kato M, Hori H, Inoue T, Iga J, Iwata M, Inagaki\nsymptoms associated with dementia. Int T et al. Discontinuation of antidepressants after\nPsychogeriatr 2020;32(5):567–72 (https://doi. remission with antidepressant medication in\norg/10.1017/s104161022000037x). major depressive disorder: a systematic review\nand meta-analysis. Mol Psychiatry. 2021;26(1):118–\n127. Knapp M, Thorgrimsen L, Patel A, Spector A,\n33 (https://doi.org/10.1038/s41380-020-0843-0).\nHallam A, Woods B et al. Cognitive stimulation\ntherapy for people with dementia: cost- 135. Zhou D, Lv Z, Shi L, Zhou X, Lin Q, Chen X et al.\neffectiveness analysis. Br J Psychiatry. Effects of antidepressant medicines on preventing\n2006;188:574–80 (https://doi.org/10.1192/bjp. relapse of unipolar depression: a pooled analysis\nbp.105.010561). of parametric survival curves. Psychol Med.\n2022;52(1):48–56 (https://doi.org/10.1017/\n128. D’Amico F, Rehill A, Knapp M, Aguirre E, Donovan\nS0033291720001610).\nH, Hoare Z et al. Maintenance cognitive",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues iris.who.int/handle/10665/371091).\n125. Towards a dementia-inclusive society: WHO toolkit\nfor dementia-friendly initiatives (DFIs). Geneva: 133. The interagency health kit 2017: medicines\nWorld Health Organization; 2021 (https://iris.who. and medical devices for 10 000 people for\nint/handle/10665/343780). approximately three months. Geneva: World\nHealth Organization; 2019 (https://iris.who.int/\n126. Burley CV, Livingston G, Knapp MR, Wimo A,\nhandle/10665/279428).\nNorman R, Brodaty H. Time to invest in prevention\nand better care of behaviors and psychological 134. Kato M, Hori H, Inoue T, Iga J, Iwata M, Inagaki\nsymptoms associated with dementia. Int T et al. Discontinuation of antidepressants after\nPsychogeriatr 2020;32(5):567–72 (https://doi. remission with antidepressant medication in\norg/10.1017/s104161022000037x). major depressive disorder: a systematic review\nand meta-analysis. Mol Psychiatry. 2021;26(1):118–\n127. Knapp M, Thorgrimsen L, Patel A, Spector A,\n33 (https://doi.org/10.1038/s41380-020-0843-0).\nHallam A, Woods B et al. Cognitive stimulation\ntherapy for people with dementia: cost- 135. Zhou D, Lv Z, Shi L, Zhou X, Lin Q, Chen X et al.\neffectiveness analysis. Br J Psychiatry. Effects of antidepressant medicines on preventing\n2006;188:574–80 (https://doi.org/10.1192/bjp. relapse of unipolar depression: a pooled analysis\nbp.105.010561). of parametric survival curves. Psychol Med.\n2022;52(1):48–56 (https://doi.org/10.1017/\n128. D’Amico F, Rehill A, Knapp M, Aguirre E, Donovan\nS0033291720001610).\nH, Hoare Z et al. Maintenance cognitive Iris.who.int/handle/10665/371091). 125."
}